PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.76 CNY | -0.13% |
|
+1.60% | +9.25% |
| May. 09 | Pacific Shuanglin Bio-pharmacy Subsidiary Gets Plasmapheresis License | MT |
| Apr. 26 | Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 2.97B 411M | Sales 2025 * | 3.39B 469M | Capitalization | 21.75B 3.01B |
|---|---|---|---|---|---|
| Net income 2024 * | 786M 109M | Net income 2025 * | 875M 121M | EV / Sales 2024 * | 7.33 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.42 x |
| P/E ratio 2024 * |
27.8
x | P/E ratio 2025 * |
24.9
x | Employees | 2,426 |
| Yield 2024 * |
0.34% | Yield 2025 * |
0.37% | Free-Float | 50.81% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.13% | ||
| 1 week | +1.60% | ||
| Current month | +1.60% | ||
| 1 month | +5.05% | ||
| 3 months | +14.68% | ||
| 6 months | +24.83% | ||
| Current year | +9.25% |
1 week
28.80
30.48
1 month
27.8830.64
Current year
21.2130.64
1 year
17.4931.25
3 years
16.2038.41
5 years
13.0950.31
10 years
8.9050.31
| Managers | Title | Age | Since |
|---|---|---|---|
Ye Hong Wang
DFI | Director of Finance/CFO | 33 | 21-03-25 |
Xiao Ying Huang
BRD | Director/Board Member | 50 | 23-10-24 |
Yu Lin Zhao
SEC | Corporate Secretary | 37 | 19-05-20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun Yin
BRD | Director/Board Member | 69 | 23-10-24 |
Jin Gang Zhang
BRD | Director/Board Member | 61 | Dec. 10 |
Shao Lan Fu
CHM | Chairman | 82 | Dec. 10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | +3.48% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 29.76 | -0.13% | 5,880,174 |
| 24-05-08 | 29.8 | -0.33% | 5,262,993 |
| 24-05-07 | 29.9 | -1.45% | 6,891,279 |
| 24-05-06 | 30.34 | +3.58% | 9,438,978 |
End-of-day quote Shenzhen S.E., May 08, 2024
More quotes
Pacific Shuanglin Bio pharmacy Co Ltd, formerly Southern Shuanglin Bio-pharmacy Co Ltd, formerly Zhenxing Biopharmaceutical & Chemical Co., Ltd., is a China-based company mainly engaged in the research, development, production and sales of blood products. The Company's main products are human albumin, intravenous immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin and rabies immunoglobulin. The Company mainly operates its business in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
29.76
CNY
Average target price
37
CNY
Spread / Average Target
+24.33%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +9.25% | 3.01B | |
| -2.70% | 88.91B | |
| +2.76% | 41.25B | |
| -13.92% | 31.99B | |
| +50.51% | 24.73B | |
| -15.25% | 15.54B | |
| -39.93% | 12.07B | |
| -9.08% | 12.05B | |
| -14.80% | 12.02B | |
| +6.22% | 8.84B |
- Stock Market
- Equities
- 000403 Stock